HFE mutations in idiopathic dilated cardiomyopathy.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 16802538)

Published in Med Klin (Munich) on March 22, 2006

Authors

Andreas Erhardt1, Claudia Mellenthin, Christian Perings, Marcus Hennersdorf, Petra Reinecke, Bodo-Eckehard Strauer, Dieter Häussinger

Author Affiliations

1: Department of Gastroenterology, Hepatology and Infectiology, Heinrich Heine University Duesseldorf, Germany. Erhardt@uni-duesseldorf.de

Articles by these authors

(truncated to the top 100)

Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 54.30

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med (2002) 36.55

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med (2012) 9.22

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med (2010) 4.76

Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology (2008) 4.53

Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet (2013) 4.39

Congenital glutamine deficiency with glutamine synthetase mutations. N Engl J Med (2005) 3.24

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. J Hepatol (2005) 3.10

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00

CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun (2006) 2.54

Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol (2011) 2.51

Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis. Blood (2006) 2.46

Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study. Ann Surg (2012) 2.40

Rickettsia felis infection acquired in Europe and documented by polymerase chain reaction. Emerg Infect Dis (2002) 2.26

Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C. Gastroenterology (2005) 2.19

Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology (2002) 2.16

Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med (2007) 2.14

iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science (2012) 2.14

An obligatory requirement for the heterotrimeric G protein Gi3 in the antiautophagic action of insulin in the liver. Proc Natl Acad Sci U S A (2007) 2.10

JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Haematologica (2008) 2.05

IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J (2003) 2.00

Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci U S A (2011) 1.98

Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration. Hepatology (2014) 1.93

Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun (2008) 1.83

Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology (2005) 1.79

Hepatic stellate cells contribute to progenitor cells and liver regeneration. J Clin Invest (2014) 1.77

Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling. Eur J Cell Biol (2011) 1.71

The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology (2007) 1.69

Early clinical experiences with the new influenza A (H1N1/09). Dtsch Arztebl Int (2009) 1.65

Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J (2012) 1.65

Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology (2010) 1.65

Disruption of hepatocellular tight junctions by vascular endothelial growth factor (VEGF): a novel mechanism for tumor invasion. J Hepatol (2004) 1.64

The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology (2009) 1.62

Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat. Hepatology (2005) 1.62

Ultrasound in tropical and parasitic diseases. Lancet (2003) 1.59

Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J Hepatol (2004) 1.55

Benzodiazepine-induced protein tyrosine nitration in rat astrocytes. Hepatology (2003) 1.53

Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. J Acquir Immune Defic Syndr (2006) 1.53

Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem (2005) 1.53

Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells (2005) 1.53

Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: implications for risk stratification and treatment. J Am Coll Cardiol (2002) 1.50

α5 β1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes. Hepatology (2012) 1.50

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD). J Hepatol (2002) 1.43

Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway. Cancer Res (2010) 1.43

Effective T-cell recall responses require the taurine transporter Taut. Eur J Immunol (2012) 1.42

Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest (2002) 1.42

Beta-blocker prophylaxis for atrial fibrillation after coronary artery bypass grafting in patients with sympathovagal imbalance. Ann Thorac Surg (2007) 1.41

The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell Signal (2012) 1.40

The niche of stellate cells within rat liver. Hepatology (2009) 1.40

BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing. Mol Pharmacol (2009) 1.38

C-reactive protein levels and clinical symptoms following gadolinium administration in hemodialysis patients. Am J Kidney Dis (2008) 1.37

Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology (2010) 1.33

Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med (2004) 1.31

Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells. Mol Cancer Ther (2010) 1.31

Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol (2012) 1.29

Hepatic stem cell niches. J Clin Invest (2013) 1.29

Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade. J Immunol (2007) 1.27

Hepatic encephalopathy and fitness to drive. Gastroenterology (2009) 1.26

Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology (2005) 1.24

Co-reactivity of plasmodial histidine-rich protein 2 and aldolase on a combined immuno-chromographic-malaria dipstick (ICT) as a potential semi-quantitative marker of high Plasmodium falciparum parasitaemia. Parasitol Res (2004) 1.24

Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology (2002) 1.23

Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J (2001) 1.21

Involvement of Toso in activation of monocytes, macrophages, and granulocytes. Proc Natl Acad Sci U S A (2013) 1.19

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int (2006) 1.16

Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices. Glia (2007) 1.16

Phenotype of the taurine transporter knockout mouse. Methods Enzymol (2007) 1.16

Hyperosmolarity and CD95L trigger CD95/EGF receptor association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation. FASEB J (2003) 1.14

Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. Gastroenterology (2004) 1.13

Reversible inhibition of mammalian glutamine synthetase by tyrosine nitration. FEBS Lett (2006) 1.12

The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia (2010) 1.12

Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol (2002) 1.11

Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neuroimage (2004) 1.10

Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochem Biophys Res Commun (2007) 1.09

Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J (2004) 1.08

Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes. FASEB J (2002) 1.07

Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS One (2010) 1.07

Trends of prevalence of primary HIV drug resistance in Germany. J Antimicrob Chemother (2007) 1.06

Correct determination of critical flicker frequency is mandatory when comparisons to other tests are made. Gut (2013) 1.06

Solitary submucous neurofibroma of the mandible: review of the literature and report of a rare case. Head Face Med (2009) 1.06

Evaluation of acoustic radiation force impulse imaging for determination of liver stiffness using transient elastography as a reference. World J Gastroenterol (2012) 1.05

The virtual liver: state of the art and future perspectives. Arch Toxicol (2014) 1.05

Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology (2002) 1.05

Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology (2003) 1.05

Involvement of integrins in osmosensing and signaling toward autophagic proteolysis in rat liver. J Biol Chem (2003) 1.05

Enhanced insulin sensitivity of gene-targeted mice lacking functional KCNQ1. Am J Physiol Regul Integr Comp Physiol (2009) 1.04

The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol (2012) 1.04

Involvement of integrins and Src in insulin signaling toward autophagic proteolysis in rat liver. J Biol Chem (2004) 1.04

Endocrine and paracrine role of bile acids. World J Gastroenterol (2008) 1.02

Prevention of bile acid-induced apoptosis by betaine in rat liver. Hepatology (2002) 1.02

Plasmodium malariae infection in spite of previous anti-malarial medication. Parasitol Res (2007) 1.01

Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology (2006) 1.01

The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes. Biol Chem (2010) 1.01

Chronic liver disease is triggered by taurine transporter knockout in the mouse. FASEB J (2006) 1.01

The osmolyte strategy of normal human keratinocytes in maintaining cell homeostasis. J Invest Dermatol (2004) 1.00

Ca2+-dependent protein kinase C isoforms induce cholestasis in rat liver. J Biol Chem (2003) 0.99

Microglia activation in hepatic encephalopathy in rats and humans. Hepatology (2011) 0.99

Hepatic and pancreatic stellate cells in focus. Biol Chem (2009) 0.99

Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes. PLoS Pathog (2013) 0.99

Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology (2006) 0.99